Firefly Neuroscience (NASDAQ: AIFF) has announced a strategic collaboration with closely held Radial, operator of the U.S.’s largest network of brain medicine clinics, to pursue the integration of Firefly’s FDA 510(k)-cleared, AI-powered Evoke EEG/ERP platform with RadialOS, Radial’s proprietary AI-native operating system for brain medicine.
According to Firefly, the planned integration will incorporate objective measures of brain function into Radial’s diagnostic process, helping clinicians develop a more complete understanding of each patient, identify potentially appropriate treatment pathways, coordinate care and track outcomes over time. This integration aims to create a more informed and personalized approach to delivering brain-medicine treatments.
The collaboration follows Radial’s August 2026 acquisition of the management services organization supporting Mindful Health Solutions, significantly expanding Radial’s clinical footprint and ability to deploy new brain-medicine technologies across a large patient population.
In a statement, Greg Lipschitz, CEO of Firefly, commented, “Integrating Evoke with RadialOS represents a compelling opportunity to place objective, data-driven insights directly into the clinical workflow. Radial is building the infrastructure required to deliver advanced brain medicine at scale. We believe the combination of its operating platform and clinical reach with Firefly’s AI-powered brain-function technology could help clinicians make more informed decisions, personalize care and objectively measure how patients respond over time.”
Firefly’s Evoke platform combines quantitative electroencephalography (qEEG) and event-related potential (ERP) testing with AI-powered analytics to provide clinicians with objective information about brain function. The platform is designed to help clinicians identify relevant brain-activity patterns, assess patients whose symptoms may overlap and monitor changes over time.
Owen Muir, MD, co-founder and CSO of Radial, remarked, “Brain medicine treatments are advancing rapidly. It’s also true that most clinics are operating on outdated infrastructure. Clinicians need better tools to translate emerging evidence into personalized, real-world care. We believe integrating Firefly’s objective brain-function data into RadialOS can help close that gap—giving clinicians actionable information at the point of care and helping more patients reach the right treatment sooner.”
Radial develops the clinical infrastructure, reimbursement capabilities and AI-guided decision-support tools needed to expand access to advanced brain-medicine treatments. Its platform supports the delivery of therapies that include transcranial magnetic stimulation (TMS), medications and other interventional approaches, offered across its network of 27 clinics in seven states.
Listen: A deep dive into EEG with Firefly Neuroscience
In this episode of The Frontier Psychiatrists, Radial co-founder and CSO Owen Muir, MD, speaks with Firefly president and COO Dave DeCaprio about EEG technology, the Evoke platform and the role of objective brain-function data in clinical care.
